"False"
Skip to content
printicon
Main menu hidden.

UCMR milestones

UCMR was established almost 20 years ago and the research environment keeps on successfully bringing about its vision of excellent interdisciplinary worldleading microbial research.

2004: UCMR is initiated

Umeå Centre for Microbial Research, UCMR, is established at Umeå University as a “bottom‐up” initiative. 

 

2006: Research infrastructure LCBU

Laboratories for Chemical Biology Umeå, LCBU, (later was named Chemical Biological Consortium Sweden, CBCS) is established as one of two nodes building up the SciLifeLab national infrastructure in chemical biology.

https://www.umu.se/en/research/infrastructure/cbcs/

 

June 2007: UCMR formally established

On 19 June, UCMR is formally established by the vice-chancellor Göran Sandberg as a centre formation at Umeå University.

 

October 2007: MIMS formally established

On 3 October, Umeå University officially  establishes Molecular Infection Medicine Sweden, MIMS, at Umeå University. It is financed through grants from the Swedish Research Council's open call for "A Laboratory for Molecular Medicine" ad modum European Molecular Biology Laboratory (EMBL) with the UCMR vision as the winning proposal.

 

2008: Linneus Centre of Excellence programme

UCMR receives 10-year funding from the Swedish Research Council's Linnaeus Centre of Excellence programme.

 

2009: Molecules for the future

“Molecules for the future” is funded by the Knut and Alice Wallenberg Foundation (KAW) and Vinnova.

 

2012: Research infrastructure FESEM

The FESEM facility is established with funding from the Swedish Research Council.

 

2012: Emmanuelle Charpentier publishes on Crispr-CAS9 in Science

Emmanuelle Charpentier and her lab at MIMS together with the team of Jennifer Doudna at the University of California, Berkeley, reported a landmark article in Science demonstrating how the bacterial protein Cas9 guided by the duplex tracrRNA-CRISPR RNA can identify targets in the invading DNA and how the system can easily be programmed and re-purposed to edit any target DNA of interest, offering a versatile genetic tool for biologists.

 

2014: Research Infrastructure Cryo-EM

A Cryo‐EM facility is established with funding from Knut och Alice Wallenbergs stiftelse, Kempe Foundation, and SciLifeLab

https://www.umu.se/en/research/infrastructure/umea-centre-for-electron-microscopy-ucem/

 

2014: National doctoral school in infection

The Swedish National Doctoral Program in Infections and Antibiotics, NDPIA, starts. The research school focuses on infection and antibiotics and covers both basic and clinical research. It is run with funding from the Swedish Research Council and coordinated by MIMS.

https://www.umu.se/en/mims/career-and-education/ndpia/

 

2020: Nobel prize to Emmanuelle Charpentier

Emmanuelle Charpentier, honorary doctor at Umeå University, and former group leader at MIMS and former visiting professor at UCMR, is awarded the 2020 Nobel Prize in Chemistry, together with Jennifer Doudna, for her groundbreaking work on the CRISPR-Cas9 gene editing technology.

 

2020: UCMR "jewel in the crown"

In the Swedish Research Council's final evaluation of the 40 different Centres of Excellence within the Linnaeus programme, UCMR is ranked among the three best in all three areas; research results, societal relevance and international competitiveness.

An international expert panel characterizes UCMR as "the jewel in the crown".

 

2022: 'EC' postdoctoral programme 

Gabriel Torrens, the first postdoctor in the 'Excellence of Choice' Postdoctoral Programme in Life Science, starts to work in UCMR PI Felipe Cava lab. The programme is funded by Kempe, KAW and Umeå University and will finance up to 15 postdoc scholarships.

The patron of the 'EC' postdoc programme is Emmanuelle Charpentier.

Latest update: 2024-03-15